Literature DB >> 11689445

PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells.

G Castoria1, A Migliaccio, A Bilancio, M Di Domenico, A de Falco, M Lombardi, R Fiorentino, L Varricchio, M V Barone, F Auricchio.   

Abstract

The p85-associated phosphatidylinositol (PI) 3-kinase/Akt pathway mediates the oestradiol-induced S-phase entry and cyclin D1 promoter activity in MCF-7 cells. Experiments with Src, p85alpha and Akt dominant-negative forms indicate that in oestradiol-treated cells these signalling effectors target the cyclin D1 promoter. Oestradiol acutely increases PI3-kinase and Akt activities in MCF-7 cells. In NIH 3T3 cells expressing ERalpha, a dominant-negative p85 suppresses hormone stimulation of Akt. The Src inhibitor, PP1, prevents hormone stimulation of Akt and PI3-kinase activities in MCF-7 cells. In turn, stimulation of Src activity is abolished in ERalpha-expressing NIH 3T3 fibroblasts by co-transfection of the dominant-negative p85alpha and in MCF-7 cells by the PI3-kinase inhibitor, LY294002. These findings indicate a novel reciprocal cross-talk between PI3-kinase and Src. Hormone stimulation of MCF-7 cells rapidly triggers association of ERalpha with Src and p85. In vitro these proteins are assembled in a ternary complex with a stronger association than that of the binary complexes composed by the same partners. The ternary complex probably favours hormone activation of Src- and PI3-kinase-dependent pathways, which converge on cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689445      PMCID: PMC125704          DOI: 10.1093/emboj/20.21.6050

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  51 in total

1.  Dopaminergic and ligand-independent activation of steroid hormone receptors.

Authors:  R F Power; S K Mani; J Codina; O M Conneely; B W O'Malley
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

2.  Direct effects of estrogen on c-fos and c-myc protooncogene expression and cellular proliferation in human breast cancer cells.

Authors:  B van der Burg; A J van Selm-Miltenburg; S W de Laat; E J van Zoelen
Journal:  Mol Cell Endocrinol       Date:  1989-07       Impact factor: 4.102

3.  Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.

Authors:  D Dubik; T C Dembinski; R P Shiu
Journal:  Cancer Res       Date:  1987-12-15       Impact factor: 12.701

4.  Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation.

Authors:  M Whitman; D R Kaplan; B Schaffhausen; L Cantley; T M Roberts
Journal:  Nature       Date:  1985 May 16-22       Impact factor: 49.962

5.  Thrombin-dependent association of phosphatidylinositol-3 kinase with p60c-src and p59fyn in human platelets.

Authors:  J S Gutkind; P M Lacal; K C Robbins
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

6.  The v-Src SH3 domain binds phosphatidylinositol 3'-kinase.

Authors:  X Liu; L E Marengere; C A Koch; T Pawson
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002).

Authors:  C J Vlahos; W F Matter; K Y Hui; R F Brown
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

8.  Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit.

Authors:  C M Pleiman; W M Hertz; J C Cambier
Journal:  Science       Date:  1994-03-18       Impact factor: 47.728

9.  PI 3-kinase: structural and functional analysis of intersubunit interactions.

Authors:  R Dhand; K Hara; I Hiles; B Bax; I Gout; G Panayotou; M J Fry; K Yonezawa; M Kasuga; M D Waterfield
Journal:  EMBO J       Date:  1994-02-01       Impact factor: 11.598

10.  Granulocyte macrophage-colony stimulating factor stimulates both association and activation of phosphoinositide 3OH-kinase and src-related tyrosine kinase(s) in human myeloid derived cells.

Authors:  S Corey; A Eguinoa; K Puyana-Theall; J B Bolen; L Cantley; F Mollinedo; T R Jackson; P T Hawkins; L R Stephens
Journal:  EMBO J       Date:  1993-07       Impact factor: 11.598

View more
  116 in total

1.  17β-Oestradiol inhibits doxorubicin-induced apoptosis via block of the volume-sensitive Cl(-) current in rabbit articular chondrocytes.

Authors:  Kousuke Kumagai; Shinji Imai; Futoshi Toyoda; Noriaki Okumura; Eiji Isoya; Hiroshi Matsuura; Yoshitaka Matsusue
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  General molecular biology and architecture of nuclear receptors.

Authors:  Michal Pawlak; Philippe Lefebvre; Bart Staels
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

Review 3.  SRC: a century of science brought to the clinic.

Authors:  Alexey Aleshin; Richard S Finn
Journal:  Neoplasia       Date:  2010-08       Impact factor: 5.715

4.  Mitochondrial DNA mutations in respiratory complex-I in never-smoker lung cancer patients contribute to lung cancer progression and associated with EGFR gene mutation.

Authors:  Santanu Dasgupta; Ethan Soudry; Nitai Mukhopadhyay; Chunbo Shao; John Yee; Stephan Lam; Wan Lam; Wei Zhang; Adi F Gazdar; Paul B Fisher; David Sidransky
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

Review 5.  Disentangling the molecular mechanisms of action of endogenous and environmental estrogens.

Authors:  Angel Nadal; Paloma Alonso-Magdalena; Cristina Ripoll; Esther Fuentes
Journal:  Pflugers Arch       Date:  2004-10-29       Impact factor: 3.657

6.  In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cells.

Authors:  Francesca De Amicis; Alessandra Russo; Paola Avena; Marta Santoro; Adele Vivacqua; Daniela Bonofiglio; Loredana Mauro; Saveria Aquila; Donatella Tramontano; Suzanne A W Fuqua; Sebastiano Andò
Journal:  Mol Nutr Food Res       Date:  2013-01-16       Impact factor: 5.914

7.  A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARalpha to target promoters.

Authors:  Nathalie Bruck; Dominique Vitoux; Christine Ferry; Vanessa Duong; Annie Bauer; Hughes de Thé; Cécile Rochette-Egly
Journal:  EMBO J       Date:  2008-12-11       Impact factor: 11.598

8.  Mutational analysis of progesterone receptor functional domains in stable cell lines delineates sets of genes regulated by different mechanisms.

Authors:  Ignacio Quiles; Lluís Millán-Ariño; Alicia Subtil-Rodríguez; Belén Miñana; Nora Spinedi; Cecilia Ballaré; Miguel Beato; Albert Jordan
Journal:  Mol Endocrinol       Date:  2009-03-19

9.  AKT regulates BRCA1 stability in response to hormone signaling.

Authors:  Andrew C Nelson; Traci R Lyons; Christian D Young; Kirk C Hansen; Steven M Anderson; Jeffrey T Holt
Journal:  Mol Cell Endocrinol       Date:  2010-01-18       Impact factor: 4.102

10.  Nutritional flavonoids impact on nuclear and extranuclear estrogen receptor activities.

Authors:  Paola Galluzzo; Maria Marino
Journal:  Genes Nutr       Date:  2006-09       Impact factor: 5.523

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.